Cloud Paweletz

16PUBLICATIONS
313CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 29, 2026
Spatially confined IL-12 programs CAR-NK through mTORC1 to coordinate antitumor immune networks.

|May 02, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancer.

|Dec 03, 2025
A Phase Ib Study of Sapacitabine and Olaparib in Patients with BRCA1/2-Mutated Metastatic Breast Cancer.

Filipa Lynce, Noah Graham, Bose S Kochupurakkal

|Sep 08, 2025
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors.

Elliott J Brea, Simon Baldacci, Neil Savage

|Aug 22, 2025
Tamoxifen induces PI3K activation in uterine cancer.

Kirsten Kübler, Agostina Nardone, Shankara Anand

|Aug 05, 2025
Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy.

Simon Baldacci, Elliott J Brea, Francesco Facchinetti

Pageof 3

Frequent Collaborators

8 joint publications

David A Barbie

6 joint publications

Pasi A Jänne

6 joint publications

Marco Campisi

6 joint publications

Navin R Mahadevan